Evaluating the attitudes and behavior of Hong Kong medical students toward receiving the COVID-19 vaccine

References

• Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis. 2011:683–8 doi:10.3109/00365548.2011.582247.
   PubMedGoogle Scholar
• Verikios G. The dynamic effects of infectious disease outbreaks: the case of pandemic influenza and human coronavirus. Socio-Econ Plan Sci. 2020;71:100898. doi:10.1016/j.seps.2020.100898.
   PubMed Web of Science ®Google Scholar
• Anderson RM, Vegvari C, Truscott J, Collyer BS. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination. The Lancet: Lancet Publishing Group; 2020. p. 1614–16.
   Google Scholar
• Microbiologist says HK needs 90% vaccination rate. RTHKHK; 2021.
   Google Scholar
• Andrews N, Tessier E, Stowe J, Gower C, Kirsebom F, Simmons R, Gallagher E, Thelwall S, Groves N, Dabrera G, et al. Duration of protection against mild and severe disease by Covid-19 vaccines. N Engl J Med. 2022 ;386(4):340–50. doi:10.1056/NEJMoa2115481.
   PubMed Web of Science ®Google Scholar
• Wong RSY. COVID-19 vaccines and herd immunity: perspectives, challenges and prospects. Malays J Pathol. 2021;43:1777.
   Web of Science ®Google Scholar
• Chemaitelly H, Tang P, Hasan MR, AlMukdad S, Yassine HM, Benslimane FM, Al Khatib HA, Coyle P, Ayoub HH, Al Kanaani Z, et al. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N Engl J Med. 2021;385(24):e83. doi:10.1056/nejmoa2114114.
   PubMed Web of Science ®Google Scholar
• The Government of Hong Kong Special Administrative R. HKSAR government donates 7.5 million doses of AstraZeneca COVID-19 vaccine to COVAX facility. The Government of Hong Kong Special Administrative Region; Press Releases 2021.
   Google Scholar
• Pottegård A, Lund LC, Karlstad Ø, Dahl J, Andersen M, Hallas J, Lidegaard Ø, Tapia G, Gulseth HL, Ruiz PLD, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdox1-S in Denmark and Norway: population based cohort study. The BMJ. 2021;373. doi:10.1136/bmj.n1114.
   PubMedGoogle Scholar
• MacDonald NE, Eskola J, Liang X, et al. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Ten threats to global health in 2019. World health organisation; 2019.
   Google Scholar
• Cobos Muñoz D, Monzón Llamas L, Bosch-Capblanch X. Exposing concerns about vaccination in low- and middle-income countries: a systematic review. Int J Public Health: Birkhauser Verlag AG. 2015;60(7):767–80. doi:10.1007/s00038-015-0715-6.
   PubMed Web of Science ®Google Scholar
• The Government of the Hong Kong Special Administrative R. Hong Kong Vaccination Dashboard
   Google Scholar
• Me RH, Rodés-Guirao L, Roser M, Beltekian D. Coronavirus pandemic (COVID-19). Our World in Data.
   Google Scholar
• Ipsos. Global attitudes : COVID-19 vaccines. 2021.
   Google Scholar
• Wang K, Wong ELY, Ho KF, et al. Change of willingness to accept covid-19 vaccine and reasons of vaccine hesitancy of working people at different waves of local epidemic in hong kong, china: repeated cross-sectional surveys. Vaccines. 2021;9(1):1–15. doi:10.3390/vaccines9010062.
   Web of Science ®Google Scholar
• Cheung E. Coronavirus: finally, Hong Kong hit the 70 per cent vaccination mark. but does it matter now and should it be aiming for 90 or even 100? South China Morning Post; 2021.
   Google Scholar
• Mahase E. Covid-19: oxford researchers halt vaccine trial while adverse reaction is investigated. BMJ (Clinical Research Ed). 2020;369:m2612. doi:10.1136/bmj.m2612.
   PubMedGoogle Scholar
• Kwok KO, Li KK, Wei WI, Tang A, Wong SYS, Lee SS. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: a survey. Int J Nurs Stud. 2021;114:103854. doi:10.1016/j.ijnurstu.2020.103854.
   PubMed Web of Science ®Google Scholar
• Report of the sage working group on vaccine hesitancy. 2014.
   Google Scholar
• Ipsos. Global attitudes on a COVID-19 vaccine. 2020.
   Google Scholar
• Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, Ng RWY, Lai CKC, Boon SS, Lau JTF, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. 2021;39(7):1148–56. doi:10.1016/j.vaccine.2020.12.083.
   PubMed Web of Science ®Google Scholar
• Hong J. BioNtech vaccine uptake jumps in Hong Kong as younger residents qualify. Bloomberg; 2021.
   Google Scholar
• A head-to-head comparison of the Sinovac and BioNTech vaccine. OT&P Healthcare; 2022.
   Google Scholar
• Kreps S, Kriner DL, Sallam M. Communication about vaccine efficacy and COVID-19 vaccine choice: evidence from a survey experiment in the United States. PLoS One. 2022;17(3):e0265011. doi:10.1371/journal.pone.0265011.
   PubMed Web of Science ®Google Scholar
• Schwarzinger M, Watson V, Arwidson P, Alla F, Luchini S. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Lancet Public Health. 2021;6(4):e210–e221. doi:10.1016/S2468-2667(21)00012-8.
   PubMed Web of Science ®Google Scholar
• Borriello A, Master D, Pellegrini A, Rose JM. Preferences for a COVID-19 vaccine in Australia. Vaccine. 2021 Jan 15;39(3):473–79. doi:10.1016/j.vaccine.2020.12.032.
   PubMed Web of Science ®Google Scholar
• Joint Scientific Committees on Vaccine Preventable D, Emerging, Zoonotic D, Chief Executive’s expert advisory p. Recommendation for 3rd dose COVID-19 vaccination. Hong Kong goverment; 2021.
   Google Scholar